-
FRISQ’s Interim Report Q2, 2022
CEO StatementDuring the quarter, Sweden approached the healthcare crisis we’re now in, and the summer months have been extremely challenging in many parts of the country. The health care situation means that the need for solutions that can help relieve the system without lowering the quality of care is both great and clear. We know …
More -
FRISQ enters into a formal exclusive process to divest the business to Cambio with a target transaction date in September 2022. CEO George Thaw steps down.
The Board of Directors of FRISQ Holding AB (FRISQ”) has decided to enter into a formal exclusive process with the objective to divest its operative business to Cambio Health Care System AB (“Cambio”). After several months of exploring the best options to secure the continued development of FRISQ, the Board has decided to accept a …
More -
Correction: Interim Report Q1, 2022
The correction refers to the EU Market Abuse Regulation. CEO StatementDuring the quarter, we have expanded our cooperation with the private healthcare provider, Capio. In addition to the multi-year agreement with Capio Elderly and Mobile Care, Capio Orthopedics signed a 3-year agreement with us. The new agreement was signed after a successful pilot project, which …
More -
FRISQ Holding AB decides on a new share issue to secure the company’s financial position
FRISQ Holding AB (“FRISQ” or “the Company”) has in a previous press release announced its intention to decide on a new share issue. FRISQ has now secured a new share issue. As the board of FRISQ didn’t receive a signed and binding share transfer agreement from Tempest SPV Ltd on Monday, the Board has, with the …
More -
FRISQ Holding AB intends to decide on a new share issue to secure the company’s financial position
As the board of FRISQ Holding AB (hereinafter "Frisq" or "the Company") did not receive a signed and binding share purchase agreement from Tempest SPV Ltd on Monday, the board intends to decide on a new share issue with the authorization given at the Extraordinary General Meeting. The purpose of the new share issue is …
More -
Report Q4 and Full Year 2021
January-December 2021 CEO StatementThe hope that healthcare could look to the time after the pandemic, including the necessary innovation work needed, were once again sharply shaken when the Omicron variant created a new wave in the last quarter of 2021 . We are therefore extra proud of what we have managed to achieve despite these …
More